Background: Five of the most abundant human milk oligosaccharides (HMOs) in human milk are 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL). Methods: A randomized, double-blind, controlled parallel feeding trial evaluated growth in healthy term infants fed a control milk-based formula (CF; n = 129), experimental milk-based formula (EF; n = 130) containing five HMOs (5.75 g/L; 2′-FL, 3-FL, LNT, 3′-SL and 6′-SL) or human milk (HM; n = 104). Results: No significant differences (all p ≥ 0.337, protocol evaluable cohort) were observed among the three groups for weight gain per day from 14 to 119 days (D) of age, irrespective of COVID-19 or combined non-COVID-19 and COVID-19 periods. There were no differences (p ≥ 0.05) among the three groups for gains in weight and length from D14 to D119. Compared to the CF group, the EF group had more stools that were soft, frequent and yellow and were similar to the HM group. Serious and non-serious adverse events were not different among groups, but more CF-fed infants were seen by health care professionals for illness from study entry to D56 (p = 0.044) and D84 (p = 0.028) compared to EF-fed infants. Conclusions: The study demonstrated that the EF containing five HMOs supported normal growth, gastrointestinal (GI) tolerance and safe use in healthy term infants.

Adequate nutrition is an essential factor in healing and immune support in pediatric patients undergoing surgery, but its importance in this setting is not consistently recognized. Standardized institutional nutrition protocols are rarely available, and some clinicians may be unaware of the importance of assessing and optimizing nutritional status. Moreover, some clinicians may be unaware of updated recommendations that call for limited perioperative fasting. Enhanced recovery protocols have been used in adult patients undergoing surgery to ensure consistent attention to nutrition and other support strategies in adult patients before and after surgery, and these are now under evaluation for use in pediatric patients as well. To support better adoption of ideal nutrition delivery, a multidisciplinary panel of experts in the fields of pediatric anesthesiology, surgery, gastroenterology, cardiology, nutrition, and research have gathered and reviewed current evidence and best practices to support nutrition goals in this setting.

Background: Childhood malnutrition remains far too common around the world today. In this paper, we discuss pediatric malnutrition in the context of protein-energy undernutrition and hidden hunger (single or multiple micronutrient deficiencies). Recent growth statistics show that nearly 150 million children under 5 years are stunted, and 50 million are wasted. At the same time, millions more children experience undernutrition of lesser severity but with negative effects on growth nonetheless. Beyond poor growth, such nutrient shortfalls can predispose children to impaired physical and mental development, which may have lifelong consequences. The World Health Organization recently set an aspirational goal “to end all forms of childhood malnutrition by 2030.” Plan of Action: Our paper proposes a stepwise strategy to raise awareness of childhood malnutrition risk and to work toward building a consensus on pediatric malnutrition screening as a pathway to ending childhood malnutrition. In a full plan for action, we propose to convene an expert Working Consensus Group on Pediatric Nutrition Screening (WCG-PNS). We propose that this group will work to (1) identify malnutrition screening tools specific for universal screening of children in hospital and community settings, (2) plan and lead healthcare professional training on how to screen for malnutrition risk, then take appropriate follow-up steps, (3) guide and advise quality improvement programs (QIPs) to facilitate incorporation of nutrition screening and interventions into everyday practice, and (4) measure and communicate potential findings in terms of health and financial outcomes. Conclusion: We recognize an urgent need for universal screening of infants and children for nutritional risk—around the world and across the continuum of care. Such screening is expected to promote early identification of children who can benefit from nutrition interventions, then ensure that these children get needed nutritional support. In this way, we aim to prevent growth impairment, which has also been associated with adverse effects on mental and physical development.

The first 1000 days is a critical window to optimize nutrition. Young children, particularly 12–24 month-olds, are an understudied population. Young children have unique nutrient needs and reach important developmental milestones when those needs are met. Intriguingly, there are differences in the dietary patterns and recommendations for young children in the US vs. globally, notably for breastfeeding practices, nutrient and food guidelines, and young child formulas (YCFs)/toddler drinks. This perspective paper compares these differences in young child nutrition and identifies both knowledge gaps and surveillance gaps to be filled. Parental perceptions, feeding challenges, and nutrition challenges are also discussed. Ultimately, collaboration among academia and clinicians, the private sector, and the government will help close young child nutrition gaps in both the US and globally.